• Inhalation Sciences’ TO3 warrant exercise period ended Aug. 27, 2026, with 4,208,774 warrants exercised for the same number of shares.
• Exercise price set at SEK 0.12 per share, raising about SEK 500,000 before costs.
• Post-registration share count to rise to 55,406,411, implying 7.6% dilution.
• Share capital expected to increase by about SEK 138,890 to SEK 1,828,421 once the new shares are registered.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inhalation Sciences Sweden AB published the original content used to generate this news brief via Cision (Ref. ID: 202608280415BITN____UKPR__SV_20260828-BIT-3446-0) on August 28, 2026, and is solely responsible for the information contained therein.